USPTO serial 79240518
MIDACORE
Reviewed by CopyMark Law Group
Reg. 5963820Status 709
- Filing date
- Status date
- Registration date
- Jan 21, 2020
- Examiner
- KETCHUM, BRENDAN J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MIDACORE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Manuel Valcarcel, Esq.
Manuel Valcarcel, Esq. Greenberg Traurig, P.A.333 S.E. 2nd Avenue, 44th FloorMiami, FL 33131UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Nano-particles for use as active ingredients in the manufacture of cosmetics; nano-particles for use as active ingredients in the manufacture of pharmaceuticals and medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system and central nervous system related diseases and disorders; nano-particles for use as carriers for cosmetics; nano-particles for use as carriers for pharmaceuticals and medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceuticals and medicines containing nano-particles for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; vaccines incorporating nano-particles | SECTION 71 - CANCELLED | — |
| 040 | Custom manufacture of nano-particles; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices to the order and specification of others | SECTION 71 - CANCELLED | — |
| 042 | Scientific research services in the field of nano-particle technology; pharmaceutical and drug development and discovery services, namely, pharmaceutical research and development; advisory services in the field of design, development and scientific research of nano-particles, pharmaceuticals and nano-medicine; product testing of nano-particles, pharmaceuticals and nano-medicine; nano-particle product quality testing, product quality evaluation and scientific research laboratory services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Midatech Limited
- Other trademarks owned by Midatech Limited
- Other trademarks owned by Midatech Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named MIDACORE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 7, 2026 | C71T | CANCELLED SECTION 71 | — |
| Jan 21, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 18, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 22, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 2, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 2, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 21, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 21, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 5, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 5, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 1, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 16, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 16, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 16, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 2, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 2, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 1, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 1, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 30, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 30, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 30, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 22, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 21, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 21, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 15, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 15, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 13, 2018 | RFNP | REFUSAL PROCESSED BY IB | — |
| Sep 27, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 27, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 25, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 24, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 21, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 17, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 17, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 13, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |